Skip to content

Author

D. Aebisher

We have 6 of 285 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Deep Learning in Multimodal Breast Cancer Imaging: From Image Reconstruction and Segmentation to Diagnosis and Treatment Response Prediction

Breast cancer imaging is central to screening, diagnosis, staging, treatment monitoring, and post-treatment surveillance, but image interpretation remains limited by variable image quality, interobserver variability, false-positive findings and heterogeneous tumor biology. This narrative review summarizes current appli...

D. Bartusik-Aebisher, Sara Czech, Jakub Szpara et al. · 0 citations
Open access Sep 2026

Recent Advances in Nanomedicine-Enhanced Photodynamic Therapy in Cutaneous Oncology: Melanoma-Dominant Evidence for Immunogenic Cell Death and Photoimmunotherapy

Although photodynamic therapy (PDT) is a recognised treatment for the premalignant keratinocytic lesion actinic keratosis (AK) and selected superficial skin cancers, poor photosensitiser delivery, restricted light penetration and tumour hypoxia can significantly restrict its effectiveness. Recent advances in nanomedici...

D. Bartusik-Aebisher, Izabella Wilk, D. Aebisher · 0 citations
#graph neural networks Review Open access Oct 2026

Artificial Intelligence in Photodynamic Therapy: From Molecular Design of Photosensitizers to Intelligent Delivery, Adaptive Dosimetry, and Personalized Prognostication of Results

Photodynamic therapy (PDT) is a minimally invasive therapeutic approach based on the light-induced activation of a photosensitizer in the presence of molecular oxygen, resulting in the generation of reactive oxygen species, including singlet oxygen. Despite local selectivity and low systemic toxicity, reproducibility o...

R. Marunych, D. Bartusik-Aebisher, Klaudia Dynarowicz et al. · 0 citations
Review Open access Sep 2026

Acquired Chemoresistance in Colorectal Cancer: Therapy-Induced Signalling Adaptation, Cellular Plasticity and Mechanism-Guided Therapeutic Strategies

The effectiveness of chemotherapy in colorectal cancer (CRC) is significantly reduced by acquired chemoresistance to 5-fluorouracil (5-FU), oxaliplatin and irinotecan. This structured narrative review synthesises mechanistic, preclinical, translational and clinical evidence underlying resistance to these agents. Distin...

D. Bartusik-Aebisher, Izabella Wilk, B. George et al. · 0 citations
Review Open access Sep 2026

Architects of Aggression: The Molecular Blueprint of Glioma Progression

Despite decades of clinical validation, glioblastoma (GBM) treatment remains tethered to a dismal 15-to-16-month survival plateau, heavily thwarted by the ys blood–brain barrier (BBB) and profound cellular heterogeneity. While the 2021 World Health Organization Classification of Tumors of the Central Nervous System (WH...

D. Aebisher, Jakub Tylutki, Angelika Myśliwiec et al. · 0 citations
Review Open access Aug 2026

Photodynamic Therapy in Cancer: Mechanisms, Photosensitizer Technology, Vitamin Modulation, and Rational Combination Design

Overall, PDT combination design should be guided by whether adjunctive agents support or undermine photosensitizer accumulation, oxygen availability, ROS-mediated cytotoxicity, and immune activation, when selected according to mechanistic compatibility.

Ilaf Naser, D. Bartusik-Aebisher, Barbara Smolak et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.